Considering that TRPM2 primarily functions as an important regulator of Ca2+ influx, we then determined whether downregulation of TRPM2 expression by osimertinib causes suppression of Ca2+ influx in EGFRm NSCLC cells. This evidence concerns the gene TRPM2 and non-small cell lung carcinoma.